Oncolytics Biotech
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -1,652 | -14,559 | -5,612 | -6,902 |
EBIT | -1,438 | -14,652 | -5,706 | -6,999 |
Net Income | -1,507 | -14,400 | -6,165 | -6,687 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -1,485 | -6,658 | -5,471 | -6,498 |
Cash | 5,202 | 12,352 | 14,626 | 15,303 |
Basic Shares | 95,857 | 101,315 | 90,999 | 84,631 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -298 | -301 | ||
EBITDA | -28,725 | -34,880 | -20,191 | -18,711 |
EBIT | -28,795 | -34,982 | -20,489 | -19,012 |
Net Income | -28,759 | -31,710 | -20,561 | -19,076 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -20,112 | -27,205 | -28,456 | -23,410 |
Cash | 5,202 | 15,942 | 34,912 | 11,666 |
Basic Shares | 95,857 | 76,483 | 67,624 | 58,029 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.01 |
2025-12-31 | $0 |
2025-09-30 | -$0.14 |
2025-06-30 | -$0.07 |
